Similar articles

• [Collateral coronary blood circulation and its role in the mechanism of the anti-ischemic (antianginal) action of pharmacologic preparations].

  Chichkanov GG, Tsorin IB. Chichkanov GG, et al. Farmakol Toksikol. 1989 Mar-Apr;52(2):15-24. Farmakol Toksikol. 1989. PMID: 2663540 Review. Russian.
• Antianginal effects of YM-16151-4 in various experimental angina models.

  Uchida W, Shibasaki K, Asano M, Takenaka T. Uchida W, et al. J Cardiovasc Pharmacol. 1993 May;21(5):701-8. doi: 10.1097/00005344-199305000-00003. J Cardiovasc Pharmacol. 1993. PMID: 7685438
• [Studies on the relation between collateral development and the effects of antianginal drugs--effects of nitroglycerin and 2-nicotinamidethyl nitrate on collateral circulation (author's transl)].

  Inou T. Inou T. Fukuoka Igaku Zasshi. 1981 Aug;72(8):440-67. Fukuoka Igaku Zasshi. 1981. PMID: 6457779 Japanese. No abstract available.
• Variable responses of highly stenotic coronary arteries and collateral circulation to intracoronary injection of nitroglycerin in patients with chronic effort angina.

  Fujita M, Yamanishi K, Miwa K, Inoko M. Fujita M, et al. Coron Artery Dis. 1994 Jun;5(6):525-9. Coron Artery Dis. 1994. PMID: 7952412
• Antianginal drugs.

  Kaverina NV, Chumburidze VB. Kaverina NV, et al. Pharmacol Ther. 1979;4(1):109-53. doi: 10.1016/0163-7258(79)90017-2. Pharmacol Ther. 1979. PMID: 88742 Review. No abstract available.